Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

MorphoSys AG. (2/28/14). "Press Release: MorphoSys AG Reports Results for Fiscal Year 2013. Financial Results at the Upper End of 2013 Guidance".

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Organisation 2 Celgene Corporation (Nasdaq: CELG)
  Group Celgene (Group)
Products Product MOR103/GSK3196165 (MorphoSys/GSK)
  Product 2 MOR202 (MorphoSys)
  Index term 2 GSK–MorphoSys: MOR103, 201306– global license for €22.5m upfront + €423m milestones + double-digit royalties
Persons Person Moroney, Simon E. (MorphoSys 1992– CEO + Founder)
  Person 2 Gutjahr-Löser, Claudia (MC Services 201710– Managing Director before MorphoSys 2002–2017 + Cassiopeia + Deutsche Bank)
     


   
Record changed: 2017-04-02

Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

More documents for MorphoSys (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top